Progress of amyloid β-protein oligomers involved in the pathogenesis of AD
Author:
Affiliation:

(Department of Geriatrics, Second Affiliated Hospital of Harbin Medical University, Harbin 150001, China)

Fund Project:

This work was supported by the Key Project of Natural Science Foundation of Heilongjiang Province (ZD2018017).

  • Article
  • | |
  • Metrics
  • |
  • Reference [33]
  • |
  • Related [20]
  • | | |
  • Comments
    Abstract:

    Alzheimer′s disease (AD) is the most common cause of dementia. The population of AD patients is numerous in China, so its prevention and treatment are imperative. The failure of therapies targeted to amyloid plaques has made the theory of neurotoxic amyloid β-protein oligomers (AβOs) more striking. In vivo and in vitro experiments have proved that the neurotoxicity of AβOs may be the cause of pathological changes in AD. This article mainly reviews the latest advances in the pathogenesis of AβOs and treatment strategies, and aims to better understand the relationship between AD and AβOs and provides references for further researches.

    Reference
    [1] Dobson CM.The amyloid phenomenon and its links with human disease[J].Cold Spring Harb Perspect Biol, 2017,9(6):a023648.DOI:10.1101/cshperspect.a023648.
    [2] 王英全, 梁景宏, 贾瑞霞, 等.2020-2050年中国阿尔茨海默病患病情况预测研究[J].阿尔茨海默病及相关病, 2019, 2(1):289-298.DOI:10.3969/j.issn.2096-5516.2019.01.012.Wang YQ, Liang JH, Jia RX, et al.Alzheimer disease in China(2015-2050)estimated using the 1% population sampling survey in 2015[J].Chin J Alzheimer′s Dis Relat Disord, 2019,2(1):289-298.DOI:10.3969/j.issn.2096-5516.2019.01.012.
    [3] Alzheimer′s Association.2016 Alzheimer′s disease facts and figures[J].Alzheimers Dement, 2016,12(4):459-509.DOI:10.1016/j.jalz.2016.03.001.
    [4] de la Monte SM.The full spectrum of Alzheimer′s disease is rooted in metabolic derangements that drive type 3 diabetes[J].Adv Exp Med Biol, 2019,1128:45-83.DOI:10.1007/978-981-13-3540-2_4.
    [5] Alzheimer A, Eorreni L, Borghi R, et al.Uber eine eigenartige Erkrankung der Hirnrinde[J].Allg Z Psychiat Med, 1907,64:146-148.
    [6] Araki W.Reversibility of Abeta oligomer neurotoxicity[J].Oncotarget, 2017,8(31):50335-50336.DOI:10.18632/oncotarget.19083.
    [7] 安鹏远, 王钦文, 徐淑君.不同聚集状态的Aβ寡聚体在阿尔茨海默病发生中的作用机制研究进展[J].生物化学与生物物理进展, 2016,43(2):109-114.DOI:10.16476/j.pibb.2015.0277.An PY, Wang QW, Xu SJ.The role and underlying mechanism of differently aggregated component of oligomericβ-amyloid protein in the progress of Alzheimer′s disease[J].Prog Biochem Biophys, 2016,43(2):109-114.DOI:10.16476/j.pibb.2015.0277.
    [8] Logovinsky V, Satlin A, Lai R, et al.Safety and tolerability of BAN2401 — a clinical study in Alzheimer′s disease with a protofibril selective Aβ antibody[J].Alzheimers Res Ther, 2016,8(1):14.DOI:10.1186/s13195-016-0181-2.
    [9] Miranker AD.Unzipping the mysteries of amyloid fiber formation[J].Proc Natl Acad Sci USA, 2004,101(13):4335-4336.DOI:10.1073/pnas.0401163101.
    [10] Wetzel R, Shivaprasad S, Williams AD.Plasticity of amyloid fibrils[J].Biochemistry, 2007,46(1):1-10.DOI:10.1021/bi0620959.
    [11] Harris P, Fernandez Suarez M, Surace EI, et al.Cognitive reserve and Aβ1-42 in mild cognitive impairment (Argentina-Alzheimer′s Disease Neuroimaging Initiative)[J].Neuropsychiatr Dis Treat, 2015,11:2599-2604.DOI:10.2147/NDT.S84292.
    [12] Reiman EM.Alzheimer′s disease:attack on amyloid-beta protein[J].Nature, 2016,537(7618):36-37.DOI:10.1038/537036a.
    [13] Sebollela A, Mustata GM, Luo K, et al.Elucidating molecular mass and shape of a neurotoxic Aβ oligomer[J].ACS Chem Neuro-sci, 2014,5(12):1238-1245.DOI:10.1021/cn500156r.
    [14] 苗素云, 倪丽艳, 王利, 等.睡眠剥夺和海马依赖性记忆[J].中国神经精神疾病杂志, 2017,43(4):253-256.DOI:10.3969/j.issn.1002-0152.2017.04.014.Miao SY, Ni LY, Wang L, et al.Sleep deprivation and hippocampus-dependent memory[J].Chin J Nerv Ment Dis, 2017,43(4):253-256.DOI:10.3969/j.issn.1002-0152.2017.04.014.
    [15] Pike CJ, Burdick D, Walencewicz AJ, et al.Neurodegeneration induced by beta-amyloid peptides in vitro:the role of peptide assembly state[J].J Neurosci, 1993,13(4):1676-1687.DOI:10.1523/JNEUROSCI.13-04-01676.1993.
    [16] Shankar GM, Li S, Mehta TH, et al.Amyloid-beta protein dimers isolated directly from Alzheimer′s brains impair synaptic plasticity and memory[J].Nat Med, 2008,14(8):837-842.DOI:10.1038/nm1782.
    [17] Forny-Germano L, Lyra e Silva NM, Batista AF, et al.Alzheimer′s disease-like pathology induced by amyloid-beta oligomers in nonhuman primates[J].J Neurosci, 2014,34(41):13629-13643.DOI:10.1523/JNEUROSCI.1353-14.2014.
    [18] Yasumoto T, Takamura Y, Tsuji M, et al.High molecular weight amyloid β1-42 oligomers induce neurotoxicity via plasma membrane damage[J].FASEB J, 2019,33(8):9220-9234.DOI:10.1096/fj.201900604R.
    [19] Tamagno E, Guglielmotto M, Monteleone D, et al.The Unexpected role of Aβ1-42 monomers in the pathogenesis of Alzheimer′s disease[J].J Alzheimers Dis, 2018,62(3):1241-1245.DOI:10.3233/JAD-170581.
    [20] Ciudad S, Puig E, Botzanowski T, et al.Aβ(1-42) tetramer and octamer structures reveal edge conductivity pores as a mechanism for membrane damage[J].Nat Commun, 2020,11(1):3014.DOI:10.1038/s41467-020-16566-1.
    [21] Angelova PR, Abramov AY.Interaction of neurons and astrocytes underlies the mechanism of Aβ-induced neurotoxicity[J].Biochem Soc Trans, 2014,42(5):1286-1290.DOI:10.1042/BST20140153.
    [22] Opazo P, Viana da Silva S, Carta M, et al.CaMKⅡ metaplasticity drives abeta oligomer-mediated synaptotoxicity[J].Cell Rep, 2018,23(11):3137-3145.DOI:10.1016/j.celrep.2018.05.036.
    [23] Izuo N, Murakami K, Fujihara Y, et al.An App knock-in mouse inducing the formation of a toxic conformer of Aβ as a model for evaluating only oligomer-induced cognitive decline in Alzheimer′s disease[J].Biochem Biophys Res Commun, 2019,515(3):462-467.DOI:10.1016/j.bbrc.2019.05.131.
    [24] Lacor PN, Buniel MC, Furlow PW, et al.Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer′s disease[J].J Neurosci, 2007,27(4):796-807.DOI:10.1523/JNEUROSCI.3501-06.2007.
    [25] 薛华, 马英杰, 赵东芹.树突棘与神经相关疾病[J].山东师范大学学报(自然科学版), 2020,35(2):232-235.DOI:10.3969/j.issn.1001-4748.2020.02.014.Xue H, Ma YJ, Zhao DQ.Dendritic spines and nervous associated diseases[J].J Shandong Norm Univ (Nat Sci),2020,35(2):232-235.DOI:10.3969/j.issn.1001-4748.2020.02.014.
    [26] Shea D, Hsu CC, Bi TM, et al.Alpha-sheet secondary structure in amyloid beta-peptide drives aggregation and toxicity in Alzheimer′s disease[J].Proc Natl Acad Sci USA, 2019,116(18):8895-8900.DOI:10.1073/pnas.1820585116.
    [27] Cummings J, Lee G, Ritter A, et al.Alzheimer′s disease drug development pipeline:2020[J].Alzheimers Dement (N Y), 2020,6(1):e12050.DOI:10.1002/trc2.12050.
    [28] Sevigny J, Chiao P, Bussière T, et al.The antibody aducanumab reduces Aβ plaques in Alzheimer′s disease[J].Nature, 2016,537(7618):50-56.DOI:10.1038/nature19323.
    [29] Knopman DS, Jones DT, Greicius MD.Failure to demonstrate efficacy of aducanumab:an analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019[J].Alzheimers Dement, 2021,17(4):696-701.DOI:10.1002/alz.12213.
    [30] Tolar M, Abushakra S, Hey JA, et al.Aducanumab, gantenerumab, BAN2401, and ALZ-801 — the first wave of amyloid-targeting drugs for Alzheimer′s disease with potential for near term approval[J].Alzheimers Res Ther, 2020,12(1):95.DOI:10.1186/s13195-020-00663-w.
    [31] Ostrowitzki S, Lasser RA, Dorflinger E, et al.A phase Ⅲ rando-mized trial of gantenerumab in prodromal Alzheimer′s disease[J].Alzheimers Res Ther, 2017,9(1):95.DOI:10.1186/s13195-017-0318-y.
    [32] Tolar M, Abushakra S, Sabbagh M.The path forward in Alzheimer′s disease therapeutics:reevaluating the amyloid cascade hypothesis[J].Alzheimers Dement, 2020,16(11):1553-1560.DOI:10.1016/j.jalz.2019.09.075.
    [33] Fantini J, Chahinian H, Yahi N.Progress toward Alzheimer′s disease treatment:leveraging the Achilles′ heel of Aβ oligomers?[J].Protein Sci, 2020,29(8):1748-1759.DOI:10.1002/pro.3906.
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation
Share
Article Metrics
  • Abstract:401
  • PDF: 904
  • HTML: 0
  • Cited by: 0
History
  • Received:August 06,2020
  • Online: August 30,2021
Article QR Code